Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

Tentative Approvals for: Aurobindo

« Back to Dashboard
Applicant Generic Name NDA Strength Dosage Form
Aurobindo Pharma Ltd
emtricitabine; tenofovir disoproxil fumarate
090513200MG; 300MGTABLET; ORAL
Aurobindo Pharma Ltd
abacavir sulfate; lamivudine
02229560MG; 30MGTABLET; ORAL
Aurobindo Pharma Ltd
tadalafil
2062852.5MGTABLET;ORAL
Aurobindo Pharma Usa
atomoxetine hydrochloride
079016100MGCAPSULE; ORAL
Aurobindo Pharma Usa
pregabalin
20532175MGCAPSULE;ORAL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot